Prothena Biosciences specializes in developing therapeutics for neurodegenerative and rare peripheral amyloid diseases, focusing on the biology of misfolded proteins.

Prothena Biosciences

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Prothena Corporation plc Ordinary Shares

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 17, 2024 5:55 AM	b016a535
news daily refresh	general	Dec 4, 2024 2:16 PM	37ba3875
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 17, 2024 5:55 AM	ecf72659
crunchbase trigger	general	Nov 27, 2024 12:50 PM	275516d5
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general	Oct 17, 2024 5:55 AM	30f69dd4
news basic	general	Dec 4, 2024 2:13 PM	319f5647
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PROTHENA

Prothena Biosciences

Last Close

14.44

22/11 21:00

Market Cap

818.97M

Beta: -

Volume Today

468.84K

Avg: -